The role of interindividual variation in human carcinogenesis

Journal of Nutrition

Volumn 129, Issue 2 SUPPL., 1999, Pages

  Lai, Cong ^a   Shields, Peter G ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Carcinogen metabolism; Carcinogenesis; Epidemiology; Genetic polymorphism; Nutrition

Indexed keywords

APOPTOSIS; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONFERENCE PAPER; DNA DAMAGE; DNA REPAIR; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN;

NICOTIANA TABACUM;

EID: 0032959232     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/129.2.552s     Document Type: Conference Paper

References (34)

1. Ankathil, R., Bhattathiri, N.V., Francis, J.V., Ratheesan, K., Jyothish, B., Chandini, R., Roy, D.D., Elizabeth, A.K. & Nair, M.K. (1996) Mutagen sensitivity as a predisposing factor in familial oral cancer. Int. J. Cancer 69: 265-267.
2. Anttila, S., Luostarinen, L., Hirvonen, A., Elovaara, E., Karjalainen, A., Nurminen, T., Hayes, J. D., Vainio, H. & Ketterer, B. (1995) Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: association with GSTM1 polymorphism, smoking, and asbestos exposure. Cancer Res. 55: 3305-3309.
3. Badawi, A.F., Stern, S.J., Lang, N.P. & Kadlubar, F.F. (1996) Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility. In: Genetics and Cancer Susceptibility: Implications for Risk Assessment (Walker, C., Groopman, J., Slaga, T. J. & Klein-Szanto, A., eds.), pp. 109-140. Wiley-Liss, Inc., New York, NY.
4. Boffetta, P. (1995) Sources of bias, effect of confounding in the application of biomarkers to epidemiological studies. Toxicol. Lett. 77: 235-238.
5. Bosron, W.F. & Li, T.K. (1986) Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology 6: 502-510.
6. Bourhis, J., Lubin, R., Roche, B., Koscielny, S., Bosq, J., Dubois, I., Talbot, M., Marandas, P., Schwaab, G., Wibault, P., Luboinski, B., Eschwege, F. & Soussi, T. (1996) Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma. J. Natl. Cancer Inst. 88: 1228-1233.
7. Cloos, J., Braakhuis, B.J., Steen, I., Copper, M.P., de Vries, N., Nauta, J.J. & Snow, G.B. (1994) Increased mutagen sensitivity in head-and-neck squamous-cell carcinoma patients, particularly those with multiple primary tumors. Int. J. Cancer 56: 816-819.
8. Cloos, J., Spitz, M.R., Schantz, S.P., Hsu, T.C., Zhang, Z.F., Tobi, H., Braakhuis, B.J. & Snow, G.B. (1996) Genetic susceptibility to head and neck squamous cell carcinoma. J. Natl. Cancer Inst. 88: 530-535.
9. Felton, J.S., Knize, M.G., Shen, N.H., Andresen, B.D., Bjeldanes, L.F. & Hatch, F.T. (1986) Identification of the mutagens in cooked beef. Environ. Health Perspect. 67: 17-24.
10. Grinberg-Funes, R.A., Singh, V.N., Perera, F.P., Bell, D.A., Young, T.L, Dickey, C., Wang, L.W. & Santella, R.M. (1994) Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-S-transferase M1 genotype. Carcinogenesis 15: 2449-2454.
11. Hall, J., English, D.R., Artuso, M., Armstrong, B.K. & Winter, M. (1994) DNA repair capacity as a risk factor for non-melanocytic skin cancer - a molecular epidemiological study. Int. J. Cancer 58: 179-184.
12. Harris, C.C. (1989) Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair. Carcinogenesis 10: 1563-1566.
13. Harty, L.C., Caporaso, N.E., Hayes, R.B., Winn, D.M., Bravo-Otero, E., Blot, W.J., Kleinman, D.V., Brown, L.M., Armenian, H.K., Fraumeni, J.F., Jr. & Shields, P.G. (1997) Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers [see comments]. J. Natl. Cancer Inst. 89: 1698-1705.
14. Hill, A.B. (1965) The environment and disease: association or causation. Proc. R. Soc. Med. 58: 295-300.
15. Hong, W.K. & Sporn, M.B. (1997) Recent advances in chemoprevention of cancer. Science (Washington, DC) 278: 1073-1077.
16. Kadlubar, F., Kaderlik, R.K., Mulder, G.J., Lin, D., Butler, M.A., Teitel, C.H., Minchin, R.F., Ilett, K.F., Friesen, M.D., Bartsch, H., Nagao, M., Esumi, H., Sugimura, T. & Lang, N.P. (1995) Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon Carcinogenesis. Proc. Princess Takamatsu Symp. 23: 207-213.
17. Kawajiri, K., Eguchi, H., Nakachi, K., Sekiya, T. & Yamamoto, M. (1996) Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res. 56: 72-76.
18. Kinzler, K.W. & Vogelstein, B. (1997) Gatekeepers and caretakers. Nature (Lond) 386: 761-763.
19. Ma, J., Stampfer, M.J., Giovannucci, E., Artigas, C., Hunter, D.J., Fuchs, C., Willett, W.C., Selhub, J., Hennekens, C.H. & Rozen, R. (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 57: 1098-1102.
20. Nakachi, K., Imai, K., Hayashi, S., Watanabe, J. & Kawajiri, K. (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res. 51: 5177-5180.
21. Nakajima, T., Elovaara, E., Anttila, S., Hirvonen, A., Camus, A.M., Hayes, J.D., Ketterer, B. & Vainio, H. (1995) Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis 16: 707-711.
22. Okada, T., Kawashima, K., Fukushi, S., Minakuchi, T. & Nishimura, S. (1995) Association between a cytochrome P450 CYPIA1 genotype and incidence of lung cancer. Pharmacogenetics 4: 333-340.
23. Pandita, T.K. & Hittelman, W.N. (1995) Evidence of a chromatin basis for increased mutagen sensitivity associated with multiple primary malignancies of the head and neck. Int. J. Cancer 61: 738-743.
24. Rothman, N., Poirier, M.C., Baser, M.E., Hansen, J.A., Gentile, C., Bowman, E.D. & Strickland, P.T. (1990) Formation of polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells during consumption of charcoal-broiled beef. Carcinogenesis 11: 1241-1243.
25. Rothman, N., Correa-Villasenor, A., Ford, D.P., Poirier, M.C., Haas, R., Hansen, J.A., O'Toole, T. & Strickland, P.T. (1993) Contribution of occupation and diet to white blood cell polycyclic aromatic hydrocarbon-DNA adducts in wildland firefighters. Cancer Epidemiol. Biomark. Prev. 2: 341-347.
26. Ryberg, D., Kure, E., Lystad, S., Skaug, V., Stangeland, I., Mercy, I., Borresen, A.L. & Haugen, A. (1994) p53-mutations in lung tumors. Relationship to putative susceptibility markers for cancer. Cancer Res. 54: 1551-1555.
27. Sinha, R. & Rothman, N. (1997) Exposure assessment of heterocyclic amines (HCAs) in epidemiologic studies. Mutat. Res. 376: 195-202.
28. Snyderwine, E.G. (1994) Some perspectives on the nutritional aspects of breast cancer research. Food-derived heterocyclic amines as etiologic agents in human mammary cancer. Cancer 74: 1070-1077.
29. Spitz, M.R., Hoque, A., Trizna, Z., Schantz, S.P., Amos, C.I., King, T.M., Bondy, M.L., Hong, W.K. & Hsu, T.C. (1994) Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract [see comments]. J. Natl. Cancer Inst. 86: 1681-1684.
30. Vaury, C., Laine, R., Noguiez, P., de Coppet, P., Jaulin, C., Praz, F., Pompon, D. & Amor-Gueret, M. (1995) Human glutathione S-transferase M1 null genotype is associated with a high inducibility of cytochrome P450 1A1 gene transcription. Cancer Res. 55: 5520-5523.
31. Vineis, P. & Porta, M. (1996) Causal thinking, biomarkers, and mechanisms of Carcinogenesis. J. Clin. Epidemiol. 49: 951-956.
32. Wei, Q., Matanoski, G.M., Farmer, E.R., Hedayati, M.A. & Grossman, L. (1994) DNA repair and susceptibility to basal cell carcinoma: a case-control study. Am. J. Epidemiol. 140: 598-607.
33. Xu, Y.L., Carr, L.G., Bosron, W.F., Li, T.K. & Edenberg, H.J. (1988) Genotyping of human alcohol dehydrogenases at the ADH2 and ADH3 loci following DNA sequence amplification. Genomics 2: 209-214.
34. Yoshida, A. (1992) Molecular genetics of human aldehyde dehydrogenase. Pharmacogenetics. 2: 139-147.